Identification of the Novel Oncogenic Role of SAAL1 and Its Therapeutic Potential in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide, affecting over 700,000 people per year. The treatment effect in advanced HCC is still disappointing and prognosis of advanced HCC remains poor. Hence, to find more effective therapeutic targets to improve the treat...
Main Authors: | Pei-Yi Chu, Shiao-Lin Tung, Kuo-Wang Tsai, Fang-Ping Shen, Shih-Hsuan Chan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/7/1843 |
Similar Items
-
Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma
by: Joycelyn J. X. Lee, et al.
Published: (2015-10-01) -
The SAAL Process. Architecture and Partecipation 1974-1976, Serralves, Porto, 2015
by: Matteo Sintini
Published: (2017-03-01) -
Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
by: Nichola Cruickshanks, et al.
Published: (2017-07-01) -
EL BARRIO DE SÃO VICTOR DE ÁLVARO SIZA: ENTRE LA TEORÍA Y LA PRÁCTICA DE LAS OPERACIONES SAAL / District of São Victor of Álvaro Siza: between theory and practice of the saal operations
by: Aitor Varea Oro
Published: (2013-11-01) -
SAAL : um programa de habitação popular no processo revolucionário
by: Gaspar Martins Pereira
Published: (2014-01-01)